New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export RADX’s income statement to Excel — free account
Radiopharm Theranostics Limited - Sponsored ADR
RADXRadiopharm Theranostics Limited - Sponsored ADR’s revenue for fiscal 2026 (year ended June 2026) was $1.9 million, down 20.2% from fiscal 2025.
0.63
0.04
−5.97%
After hours trading: 0.60, down 4.76%, last trade Fri 4:27pm Eastern.
Follow RADX
Alert me
| Dec '25 | Jun '26 | |
|---|---|---|
Free Cash Flow |
(68.16) | (88.91) |
| Other line items | ||
Cash ROIC |
(122.94%) | (495.06%) |
Columns are period end dates · fundamentals updated Nov 2, 2026